Literature DB >> 24297690

Association of heart rate at hospital discharge with mortality and hospitalizations in patients with heart failure.

Marlena V Habal1, Peter P Liu, Peter C Austin, Heather J Ross, Gary E Newton, Xuesong Wang, Jack V Tu, Douglas S Lee.   

Abstract

BACKGROUND: Heart failure (HF) is associated with a high burden of morbidity and mortality. Hospital discharge is an opportunity for identification of modifiable prognostic factors in the transition to chronic HF. METHODS AND
RESULTS: We examined the association of discharge heart rate with 30-day and 1-year mortality and hospitalization outcomes in a cohort of 9097 patients with HF discharged from hospital. Discharge heart rate was categorized into predefined groups: 40 to 60 (n=1333), 61 to 70 (n=2170), 71 to 80 (n=2631), 81 to 90 (n=1700), and >90 bpm (n=1263). There was a significant increase in all-cause 30-day mortality with adjusted odds ratios of 1.59 (95% confidence interval [CI], 1.18-2.14; P=0.003) for discharge heart rates 81 to 90 bpm and 1.56 (95% CI, 1.13-2.16; P=0.007) for heart rates>90 bpm when compared with the reference group (heart rates, 61-70 bpm). Cardiovascular death risk at 30 days was also higher with adjusted odds ratio 1.59 (discharge heart rates, 81-90 bpm; 95% CI, 1.09-2.33; P=0.017) and 1.65 (discharge heart rates, >90 bpm; 95% CI, 1.09-2.48; P=0.017). One-year all-cause mortality (adjusted odds ratio, 1.41; 95% CI, 1.16-1.72; P<0.001) and cardiovascular death (adjusted odds ratio, 1.47; 95% CI, 1.12-1.92; P=0.005) were higher with discharge heart rates>90 bpm when compared with the reference group (heart rates, 40-60 bpm). Readmissions for HF (adjusted hazard ratio, 1.26; 95% CI, 1.04-1.54; P=0.021) and cardiovascular disease (adjusted hazard ratio, 1.29; 95% CI, 1.08-1.54; P=0.004) within 30 days were also higher with discharge heart rates>90 bpm.
CONCLUSIONS: Higher discharge heart rates were associated with greater risk of all-cause and cardiovascular mortality≤1-year follow-up and an elevated risk of 30-day readmission for HF and cardiovascular disease.

Entities:  

Keywords:  heart failure; heart rate; hospitalization; mortality; prognosis

Mesh:

Year:  2013        PMID: 24297690     DOI: 10.1161/CIRCHEARTFAILURE.113.000429

Source DB:  PubMed          Journal:  Circ Heart Fail        ISSN: 1941-3289            Impact factor:   8.790


  17 in total

Review 1.  Patient Characteristics Predicting Readmission Among Individuals Hospitalized for Heart Failure.

Authors:  Melissa O'Connor; Christopher M Murtaugh; Shivani Shah; Yolanda Barrón-Vaya; Kathryn H Bowles; Timothy R Peng; Carolyn W Zhu; Penny H Feldman
Journal:  Med Care Res Rev       Date:  2015-07-14       Impact factor: 3.929

Review 2.  Decision-making under uncertainty in advanced heart failure.

Authors:  Theo E Meyer; Michael S Kiernan; David D McManus; Jeffrey Shih
Journal:  Curr Heart Fail Rep       Date:  2014-06

Review 3.  Drug therapies in chronic heart failure: a focus on reduced ejection fraction.

Authors:  Helena Bolam; Geraint Morton; Paul R Kalra
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

4.  In-hospital heart rate reduction and its relation to outcomes of heart failure patients with sinus rhythm: Results from the Polish part of the European Society of Cardiology Heart Failure Pilot and Long-Term Registries.

Authors:  Paweł Balsam; Michał Peller; Sonia Borodzicz; Agnieszka Kapłon-Cieślicka; Krzysztof Ozierański; Agata Tymińska; Michał Marchel; Maria G Crespo-Leiro; Aldo Pietro Maggioni; Jarosław Drożdż; Marcin Grabowski; Krzysztof J Filipiak; Grzegorz Opolski
Journal:  Cardiol J       Date:  2018-08-29       Impact factor: 2.737

5.  β-Blocker Doses and Heart Rate in Patients with Heart Failure: Results from the National Norwegian Heart Failure Registry.

Authors:  Torfinn Eriksen-Volnes; Arne Westheim; Lars Gullestad; Eva Kjøl Slind; Morten Grundtvig
Journal:  Biomed Hub       Date:  2020-02-21

6.  Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs.

Authors:  Adam D DeVore; Phillip J Schulte; Robert J Mentz; N Chantelle Hardy; Jacob P Kelly; Eric J Velazquez; Juan F Maya; Adrian Kielhorn; Harshali K Patel; Shelby D Reed; Adrian F Hernandez
Journal:  Am J Cardiol       Date:  2015-12-30       Impact factor: 2.778

7.  Nemaline myopathy and heart failure: role of ivabradine; a case report.

Authors:  Filippo M Sarullo; Giuseppe Vitale; Antonino Di Franco; Silvia Sarullo; Ylenia Salerno; Laura Vassallo; Emanuela Petrona Baviera; Stefania Marazia; Giorgio Mandalà; Gaetano A Lanza
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

8.  Heart rate at hospital discharge in patients with heart failure is associated with mortality and rehospitalization.

Authors:  Warren K Laskey; Ihab Alomari; Margueritte Cox; Phillip J Schulte; Xin Zhao; Adrian F Hernandez; Paul A Heidenreich; Zubin J Eapen; Clyde Yancy; Deepak L Bhatt; Gregg C Fonarow
Journal:  J Am Heart Assoc       Date:  2015-04-22       Impact factor: 5.501

Review 9.  Drug therapy for heart failure in older patients-what do they want?

Authors:  Donah Zachariah; Jacqueline Taylor; Nigel Rowell; Clare Spooner; Paul R Kalra
Journal:  J Geriatr Cardiol       Date:  2015-03       Impact factor: 3.327

10.  Association of Heart Rate Trajectory Patterns with the Risk of Adverse Outcomes for Acute Heart Failure in a Heart Failure Cohort in Taiwan.

Authors:  Cheng-Chun Wei; Kou-Gi Shyu; Kuo-Liong Chien
Journal:  Acta Cardiol Sin       Date:  2020-09       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.